For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly ...

California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the ...

California will offer CalRx-branded biosimilar insulin glargine pens for $11 per pen beginning January 1, 2026.

Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two years later than the governor originally promised.

Governor Gavin Newsom unveiled a plan Thursday to dramatically lower insulin costs for California's 3.5 million diabetes patients through the state's CalRx program. Beginning January 1, patients will ...